FI
AGRX

Fosun International’s Agile Therapeutics AGRX Stock Holding History

Fosun International’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-206
Closed -$580K – 307
2019
Q2 		$580K Hold
206
– – 0.04% 210
2019
Q1 		$630K Sell
206
-27
-12% -$57.2K 0.04% 202
2018
Q4 		$286K Hold
233
– – 0.02% 260
2018
Q3 		$180K Buy
+233
New +$171K 0.01% 236

Other funds holding AGRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fosun International's AGRX Position: Q3 2019 in Review

Fosun International sold out of Agile Therapeutics (AGRX) in Q3 2019, closing a stake of 206 shares — an estimated $580K sold.

Fosun International first reported a position in AGRX in Q3 2018 and held it in 4 quarters. The position peaked at $630K in Q1 2019. 33 funds tracked by Wall St. Rank hold AGRX as of Q3 2019.

  • Fosun International reported no remaining Agile Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 206 Agile Therapeutics shares in Q3 2019, an estimated $580K.
  • Fosun International first reported a position in Agile Therapeutics in Q3 2018 and held it in 4 quarters.
  • Fosun International's Agile Therapeutics position peaked at $630K in Q1 2019.
  • 33 funds tracked by Wall St. Rank held Agile Therapeutics as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.